Log inSign up
AAOIFI No. 21 screening

Is RPRX halal?

Royalty Pharma plc

Not halal

Royalty Pharma plc did not pass AAOIFI screening. The failed check is shown below.

Checked: 13 October 2026

Exchange

NASDAQ

Price

60.96

Day

+2.25%

Market cap

$33.39B

Industry

Biotechnology

Sector

Healthcare

What the company does

Royalty Pharma buys drug royalties: it pays inventors and universities upfront and in return collects an ongoing share of drug sales (Imbruvica, Trikafta, Tysabri). Revenue is those royalty streams.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $8.96B ÷ 36-month average market cap $15.18B = 59.0%

    59.0%

    Fail

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $18.53B ÷ 36-month average market cap $15.18B = 122.1%

    122.1%

    Fail

  • Non-compliant income / total revenue

    limit 5%

    Interest income $33.59M ÷ annual revenue $2.38B (2025) = 1.4%

    1.4%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $33.39B.

For information (AAOIFI 3/1 note): cash + receivables are 8.9% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 2 superinvestors · Average reported price: $56.07

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyRPRX's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →